Replication fork stalling at abnormal DNA structures or after collision with transcription complexes is a source of genomic instability in cancer and in developmental disorders [1] [2] [3] [4] [5] . Homologous recombination (HR) at stalled or collapsed forks can either suppress or promote genomic instability 6,7 . To study repair at stalled mammalian replication forks, we previously adapted the Escherichia coli Tus-Ter replication fork barrier (RFB) 8, 9 to trigger locus-specific fork stalling and HR on a mammalian chromosome 10 . We uncovered functions for BRCA1, BRCA2 and RAD51 in suppressing aberrant replicative HR responses at stalled forks. In wild-type cells, conservative short tract gene conversion (STGC) is the major HR product at Tus-Ter. In cells that lack BRCA1 and RAD51, approximately 85% of all Tus-Ter-induced HR events are resolved by aberrant long tract gene conversion (LTGC) 10 -a replicative response to fork stalling that is potentially analogous to break-induced replication in yeast [11] [12] [13] . BRCA1, BRCA2, RAD51 and the Fanconi anaemia (FA) genes have additional non-HR functions at stalled forks, where they protect DNA from degradation by the MRE11 nuclease 14 . BRCA1, together with its heterodimeric partner BARD1, has also been implicated in the removal of the CMG replicative helicase from the stalled fork 15 . BRCA1, BARD1 and the BRCA1-interacting protein CtIP have BRCA2-independent functions in DNA end processing [16] [17] [18] . BRCA1-BARD1 interacts with RAD51 directly and also indirectly via PALB2-BRCA2 19,20 . Thus, BRCA1 performs several functions at the stalled fork and in double-strand break (DSB) repair, only some of which are shared with BRCA2.
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To determine the rearrangement underlying the GFP -RFP + outcome, we analysed 6× Ter-HR reporter structure in Tus-Ter-induced GFP -RFP + clones (Fig. 2) . We used fluorescence-activated cell sorting (FACS) to isolate Tus-Ter-induced GFP -RFP + clones from Brca1 ∆/exon11 6× Ter-HR reporter cells, in parallel with Tus-Ter-induced GFP + RFP -(STGC) and GFP + RFP + (LTGC) controls, and analysed genomic DNA (gDNA) by Southern blotting. STGC and LTGC products revealed the expected rearrangements 10, 26 (Fig. 2a, b ). By contrast, each GFP -RFP + rearrangement had a unique structure and fell into one of two classes in BglII-restricted gDNA. Class 1 rearrangements contained a single GFP probe-hybridizing band of ≤10 kb. Class 2 rearrangements contained one invariant band of approximately 6.6 kb that co-migrated with the BglII-digested parental reporter and one smaller fragment of variable size (Fig. 2b) . PCR amplification and sequencing of the rearrangement breakpoints revealed that all Tus-Ter-induced GFP -RFP + clones contained microhomology-mediated or non-homologous tandem duplications of the RFP cassette (hereafter termed TDs), with predominant use of 1-2 bp microhomology at the TD breakpoint ( Fig. 2c and Extended Data Fig. 2 ). Class 2 rearrangements reflect inclusion of a BglII site within the TD; in other respects the two classes are similar. A detailed analysis of TD breakpoints is presented below.
Specificity of TD suppression by BRCA1
To determine whether TD suppression at Tus-Ter-stalled forks is specific to BRCA1, we studied the contribution of additional stalled fork metabolism/repair proteins to Tus-Ter-induced repair. We compared, in parallel, the effect of siRNA-mediated depletion of candidates on Tus-Ter-induced versus I-SceI-induced repair in Brca1 fl/exon11 cells versus Brca1 ∆/exon11 cells, using siRNA against luciferase as control. In Brca1 fl/exon11 cells (that is, expressing wild-type Brca1), we identified BRCA1, BARD1 and CtIP as major suppressors of Tus-Ter-induced TDs (Extended Data Fig. 3a ). CtIP acts largely independently of BRCA1 as a TD suppressor, as it does in certain other repair functions 26, 27 . By contrast, BRCA2, RAD51, FANCA, FANCD2 or SLX4 (also known as FANCP) suppressed TDs modestly or not at all, despite evidence that these proteins support Tus-Ter-induced HR, as expected from previous studies 10, 28 (Extended Data Fig. 3b ). I-SceI-induced GFP -RFP + products were not regulated by the aforementioned proteins (Extended Data Fig. 3a ). Depletion of the FANCM translocase 29 or the Bloom's syndrome helicase (BLM) 30 did not induce TDs in Brca1 fl/exon11 cells but unexpectedly increased Tus-Ter-induced TDs around 15-fold in Brca1 ∆/exon11 cells (Extended Data Fig. 3a, c) . FANCM and BLM can each disassemble late recombination intermediates but are also implicated in stalled fork metabolism 31 . Loss of FANCM or BLM affected Tus-Ter-induced TDs quantitatively but not qualitatively (Extended Data Fig. 4a ; see also TD breakpoint analysis, below). Co-depletion of FANCM and BLM in Brca1 ∆/exon11 cells produced additive effects on TD formation (Extended Data Fig. 4b ), suggesting that the two proteins act independently to suppress Tus-Ter-induced TDs.
As a further test of the relative contributions of BRCA1 and BRCA2 to TD suppression, we depleted BRCA1, BARD1, BRCA2 or RAD51 in combination with FANCM or BLM in Brca1 fl/exon11 6× Ter-HR reporter cells. Consistent with the above findings, co-depletion of BRCA1, BARD1 or CtIP with FANCM or BLM induced Tus-Ter-induced TDs, whereas co-depletion of BRCA2 or RAD51 with FANCM or BLM had a minimal article reSearcH effect on TDs (Extended Data Fig. 5a, b ). We made similar observations in Brca2 mutant (Brca2 lex1/lex2 ) ES cells 32 (Extended Data Fig. 5c ). Thus, even when Brca2 is biallelically mutated, Brca1 remains the dominant TD suppressor. The Tus-Ter system recapitulates the specific association of BRCA1 loss with small TDs originally noted in the breast cancer genome 21, 22 . We therefore propose that group 1 TDs in BRCA1 mutant breast cancer are products of aberrant stalled fork repair.
Mechanism of TD formation
Three different mechanisms could mediate TD formation at stalled forks. The first invokes breakage of both sister chromatids and their fusion by end joining (breakage-fusion; Fig. 3a ). The 'partner' sister chromatid (the sister that does not acquire a TD) would be broken and rearranged during this process. A second model invokes TD initiation by microhomology-mediated synapsis of a free DNA end generated at the stalled/collapsed rightward fork ( Fig. 3b ), priming TD formation by microhomology-mediated break-induced replication (MMBIR) 33, 34 . A third mechanism entails aberrant 'replication restart' of the stalled/collapsed leftward fork ( Fig. 3c ). By analogy with previously described RAD51-independent replication restart mechanisms [35] [36] [37] [38] , processing of the collapsed leftward fork primes extension of the stalled leading strand by a migrating bubble mechanism that resembles break-induced replication 13 (Fig. 3c ). The approaching conventional rightward fork bypasses the restarted leftward nascent strand and re-copies the TD tract before stalling at Tus-Ter (replication restart-bypass; Fig. 3c ). According to this model, the 'upstream' site of the TD breakpoint (defined in Extended Data Fig. 2a ) marks the site of displacement of the leftward nascent strand, and the 'Terproximal' site (Extended Data Fig. 2a ) is derived from a free DNA end formed at the Tus-Ter-stalled rightward fork. Note that the fork breakage shown in Fig. 3b , c is not a requirement of these models, since a free DNA end could alternatively be generated at Tus-Ter by fork regression 39 . Indeed, high frequency rearrangements observed at a site-specific RFB in Schizosaccharomyces pombe are not accompanied by evidence of fork breakage 37 .
As summarized in Fig. 3d , the breakage-fusion, MMBIR and replication restart-bypass models predict different fates of the partner sister chromatid during TD formation and/or different dependencies on end joining. To retrieve the partner sister chromatid, we induced mitotic non-disjunction during the cell cycle in which the TD formed, by treating Tus-transfected FANCM-depleted Brca1 ∆/exon11 cells with 30 μ M cytochalasin B for 24 h immediately before FACS cloning of GFP -RFP + cells ( Fig. 4a and Methods). Southern analysis of 60 independent GFP -RFP + aneuploid clones revealed no off-size GFP-hybridizing bands other than the TD itself in any clone, providing no support for the article reSearcH breakage-fusion model ( Fig. 4a and Supplementary Fig. 1 ). By contrast, 11 out of 60 GFP -RFP + clones contained two copies of the 6× Ter-HR reporter: one that had undergone a TD and one that retained the parental structure (Fig. 4b ). In eight of these clones, re-cloning failed to separate the two reporter copies, confirming that the TD and unrearranged reporter were present in the same cell (Extended Data Fig. 6a, b ). We obtained direct TD breakpoint sequences for 6 of these 8 clones. One TD breakpoint was blunt, one entailed insertion of one nucleotide and four revealed microhomology. The spontaneous non-disjunction rate for this cell line is around 1 in 1,000. The fact that 8 out of 60 CB-induced 'non-disjunction' TD clones revealed an unaltered partner sister chromatid indicates that TDs form at Tus-Ter primarily via a replicative mechanism, not by breakage-fusion. Interestingly, segmental TDs in Saccharomyces cerevisiae and E. coli are also mediated by replicative mechanisms 34, 40 .
To analyse the role of classical non-homologous end joining in TD formation, we targeted a single copy of the 6× Ter-HR reporter to the Rosa26 locus of mouse Xrcc4 fl/fl ES cells, then generated Cre-treated Xrcc4 fl/fl and Xrcc4 ∆/∆ derivatives 41 . The frequency of Tus-Ter-induced TDs in two Xrcc4 ∆/∆ clones co-depleted of BRCA1-FANCM or BRCA1-BLM was approximately 30% of that observed in two Xrcc4 fl/fl clones ( Fig. 4c, d ). We confirmed that BRCA1 and BARD1 are the dominant TD suppressors in Xrcc4 fl/fl cells (Extended Data Fig. 6c, d ). Stable lentivirus-mediated expression of wild-type Xrcc4 restored TD frequencies in Xrcc4 ∆/∆ clones to wild-type levels (Fig. 4e , f). The involvement of classical non-homologous end joining in TD formation at Tus-Ter suggests that replication restart-bypass, not MMBIR, is the principal mechanism ( Fig. 3d ). Residual Tus-Ter-induced TDs in Xrcc4 ∆/∆ cells might entail Xrcc4-independent alternative end joining. However, we cannot formally exclude contributions by breakage-fusion or MMBIR to a proportion of Tus-Ter-induced TDs.
TD breakpoint analysis
To understand the mechanisms underlying TD formation better, we analysed in detail the sequence of Tus-Ter-induced TDs from Brca1 ∆/exon11 cells depleted of FANCM, BRCA1 or BLM. TD spans varied from around 2 kb to 6 kb, which represent the technical boundaries of TD detection using this reporter (Extended Data Fig. 7a ). Tus-Ter-induced TD breakpoints revealed a modest microhomology bias (Extended Data Fig. 7b ). In total, 14 out of 237 (5.9%) article reSearcH breakpoints were homeologous, containing 1-2 bp internal mismatches within longer microhomology tracts of 4-10 bp, with no consistent strand preference of mismatch correction (Extended Data Fig. 7c ). Notably, 6 out of 231 (2.6%) TDs contained complex breakpoints (Extended Data Fig. 7d ), suggestive of microhomologymediated template switching 42 . Template switching is associated with TD formation in E. coli, break-induced replication in S. cerevisiae and alternative end joining in mammalian cells 40, [43] [44] [45] [46] [47] . It has been invoked to explain complex breakpoints associated with replication stress in the cancer genome 33, 48 . Our findings provide direct evidence of microhomology-mediated template switching at stalled mammalian replication forks.
Solitary DNA ends form at Tus-Ter
The Ter-proximal site of the TD represents the product of rightward fork stalling at Tus-Ter ( Fig. 3c ). Indeed, Ter-proximal sites were clustered near the first Ter elements encountered by the rightward fork, a minority being distributed upstream (Extended Data Fig. 7e ). By contrast, upstream TD sites were more widely distributed (Extended Data Fig. 7f ). To determine whether Ter-proximal TD sites correspond to detectable DNA lesions at Tus-Ter, we used high-throughput genome-wide translocation sequencing (HTGTS) 49, 50 to map translocation-competent DNA ends at Tus-Ter. As bait for HTGTS, we induced a Cas9-CRISPR-mediated DSB approximately 30 kb from the 6× Ter array at Rosa26 (Fig. 5 ). (The 'translocations' studied here are, strictly, intrachromosomal rearrangements.) Control I-SceI-induced two-ended DSBs should produce equal representation of (+ ) and (− ) DNA ends in HTGTS mapping (Fig. 5a ). By contrast, rightward forks arriving at Tus-Ter ( Fig. 5b ) might generate predominantly (+ ) DNA ends, whereas leftward forks (not shown) would generate (− ) DNA ends. This polarity is expected whether the DNA end is generated directly by breakage at the branch-point of the stalled fork ( Fig. 5b ) or indirectly via fork regression ( Fig. 5c ). Notably, if either sister chromatid were broken anywhere other than at the branch-point of the stalled fork, this would generate a conventional two-ended DSB with equal representation of (+ ) and (− ) DNA ends.
As expected, FANCM-depleted Brca1 ∆/exon11 cells co-transected with control I-SceI and the CRISPR-Cas9 bait vectors revealed symmetrical HTGTS distributions of (+ ) and (− ) DNA ends that mapped to the I-SceI site adjacent to the Ter array 49 (Fig. 5d ). Conversely, translocations into Tus-Ter in FANCM-depleted Brca1 ∆/exon11 cells were highly asymmetric. We noted an approximately sevenfold excess of (+ ) ends compared with (− ) ends ( Fig. 5d ), indicating that solitary DNA ends predominate at Tus-Ter-stalled forks. Tus-Ter HTGTS breakpoints were tightly focused on the Ter array and were microhomology biased in comparison to I-SceI HTGTS breakpoints, revealing a 1-2 bp microhomology preference reminiscent of Tus-Ter-induced TD breakpoints (Extended Data Fig. 8a ; compare with Extended Data Fig. 7b ). Furthermore, translocations at Tus-Ter were more abundant into the Ter sites first encountered by the approaching replication fork (Fig. 5d ). In all treatment groups, including cells containing wild-type Brca1, the distributions of Tus-Ter HTGTS breakpoints were similar ( Fig. 5e and Extended Data Fig. 8b ). However, a quantitative effect of BRCA1 on the formation of DNA ends at Tus-Ter is not excluded. In all treatment groups, the distribution of Ter-proximal TD sites (products of rightward fork stalling) was significantly shifted in comparison to the distribution of Tus-Ter HTGTS (+ ) ends (also products of rightward fork stalling; Extended Data Fig. 8b ). Taken together, these findings suggest that the Ter-proximal site of the TD breakpoint arises from a solitary DNA end generated at the Tus-Ter RFB, which is further processed before being misrepaired in Brca1 mutants to form a TD.
TD phenotype in BRCA1 mutant cancer
Our data suggest that TD suppression at stalled replication forks is an intrinsic function of BRCA1. If so, the TD phenotype might be a general feature of BRCA1 loss in cancer. To test this idea, we analysed TDs occurring in 92 cancers from the Australian Ovarian Cancer Study (AOCS; http://www.aocstudy.org/), for which whole-genome sequence, BRCA1 promoter methylation status and transcriptome data are available. We noted a strong association between loss of BRCA1 by mutation or promoter methylation and group 1 TDP (Extended Data Fig. 9 ). Re-analysis of the Sanger Institute dataset 22 using our TD algorithm confirmed that TDP group 1 is strongly associated with BRCA1 loss but not with BRCA2 loss. Indeed, in the Sanger dataset filtered to include only triple-negative breast cancers (which included almost all the group 1 TDP breast cancers), BRCA2 inactivation was negatively associated with group 1 TDP (Extended Data Fig. 9b ). In the AOCS and Sanger TNBC datasets, we observed no association between group 1 TDP and either mutation or aberrant expression of FANCM or BLM (Extended Data Fig. 10 ). Whether these genes function as TD suppressors in human tumorigenesis therefore remains to be determined.
Conclusion
We demonstrate that BRCA1 but not BRCA2 is a major suppressor of TDs at a Tus-Ter RFB in primary mammalian cells. These findings recapitulate the group 1 TD phenotype of BRCA1-mutant breast cancers 21, 22, 25 . We therefore propose that group 1 TDs in BRCA1linked cancer arise by defective processing of stalled replication forks. Extending these observations across tumour types, we observed a strong group 1 TDP in ovarian cancers that lack BRCA1. The group 1 TDP may therefore serve as a useful biomarker of BRCA1 loss in other cancer types 51 . Furthermore, our findings suggest that inactivation of BARD1 or RBBP8 (which encodes CtIP) may also be associated with group 1 TDP cancers.
Our analysis suggests that Tus-Ter-induced TDs in BRCA1 mutant cells arise by an aberrant replication restart-bypass mechanism terminated by end joining. Certain key elements of this mechanism are conserved in yeast 7, 13, 37, 38 . However, it remains to be determined precisely how BRCA1 and BARD1, of which there are no yeast orthologues, suppress these aberrant stalled fork responses. BRCA1 and BARD1 have BRCA2-independent roles in DNA end-processing and in CMG helicase unloading at the stalled fork [15] [16] [17] [18] . Thus, several distinct BRCA1-mediated functions might suppress TD formation at stalled forks. A notable aspect of this study is the finding that solitary DNA ends predominate at Tus-Ter-stalled forks. We detected these lesions in both TD-prone and control cells, suggesting that the production of solitary DNA ends is a generalized, perhaps physiological, response to fork stalling 39 . The element of TD formation that is specific to BRCA1 loss therefore appears to be the 'licensing' of an aberrant replication restart mechanism at stalled forks.
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Molecular biology and siRNAs. The vectors for Ter HR reporters described were constructed by conventional cloning methods using a previously described 6× Ter-HR and RFP-SCR reporters 10, 26 . pHIV-NAT-CD52 vectors were derived from pHIV-Zsgreen, a gift from B. Welm and Z. Werb (Addgene plasmid 18121) 52 . Ter-containing plasmids were amplified in JJC33 (Tus -) strains of E. coli. siRNA SMARTpools were purchased from Dharmacon. All plasmids used for transfection were prepared by endotoxin-free maxiprep (QIAGEN Sciences). Mouse cell lines and cell culture. Mouse ES cells were authenticated as described in the text and were periodically tested for mycoplasma contamination. Only mycoplasma-free cells were used in experiments described here. Cells were thawed on mouse embryonic fibroblast (MEF) feeders and maintained in ES medium on gelatinized plates. 10 μ g of Ter/HR reporter Rosa26-targeting plasmids per 1 × 10 7 cells were linearized using KpnI and introduced by electroporation. ES cells were seeded onto 6-cm dishes containing puromycin-resistant feeders and plates supplemented with 4 μ g ml −1 puromycin for 24 h. Individual colonies were picked 7-10 days later. Rosa26-targeted lines were screened for by PCR. Reporter cassette integration and overall structure were verified for targeted lines by Southern blotting. Multiple Brca1-deficient or Xrcc4-deficient ES clones were generated by transient adenovirus-mediated Cre expression. Rosa26 genotyping primers: Rosa26 sense 5′ -CATCAAGGAAACCCTGGACTACTG-3′ ; Ter-HR reporter antisense 5′ -CCTCGGCTAGGTAGGGGATC-3′ . Brca1 exon 11 status was determined by PCR: Brca1 5′ -sense 5′ -CTGGGTAGTTTGTAAGCATCC-3′ ; Brca1 exon 11 antisense 5′ -CAATAAACTGCTGGTCTCAGGC-3′ ; Brca1 exon 11 sense 5′ -GGAAATGGCAACTTGCCTAG-3′ ; Brca1 3′ -antisense 5′ -CTGCGAG CAGTCTTCAGAAAG-3′ . Xrcc4 status was determined by PCR: Xrcc4 5′ -sense 5′ -TTCAGCTAACCAGCATCAATAG-3′ ; floxed allele, Xrcc4 3′ -antisense 5′ -GCACCTTTGCCTACTAAGCCATCTCAC-3′ ; exon 3-deleted allele, Xrcc4 3′ -antisense 5′ -TAAGCTATTACTCCTGCATGGAGCATTATCACC-3′ 41 . Brca2 exons 26 and 27 status was determined by PCR: Brca2 intron 25 5′ -sense 5′ -TTCA GCTAACCAGCATCAATAG-3′ ; Brca2 exon 27 3′ -antisense 5′ -CGTTCTCTCCA CTCCAAGACTTTGC-3′ ; Brca2 PGK promoter 3′ -antisense 5′ -TCCATTTGTCAC GTCCTGCACGACG-3′ 32 . Exon 3-deleted, Xrcc4-deficient mouse ES cells were transduced with lentivirus expressing a single mRNA encoding Nat (nuorseothricin acetyl transferase) and human CD52 (the CAMPATH antigen), with or without wild-type mouse Xrcc4: pHIV-NAT-hCD52-EV (empty vector control) or pHIV-NAT-hCD52-mXRCC4. Stable cultures were selected and maintained in 100 μ g ml −1 nourseothricin (Jenna Bioscience AB-102L). Recombination assays. Approximately 1.6 × 10 5 cells were co-transfected in suspension with 0.35 μ g empty vector, pcDNA3β -myc NLS-Tus 10 , or pcDNA3β -myc NLS-I-SceI 53 , and 20 pmol ONTargetPlus-smartpool using Lipofectamine 2000 (Invitrogen). GFP + RFP -, GFP + RFP + and GFP -RFP + frequencies were scored 72 h after transfection by flow cytometry using a Becton Dickinson 5 Laser LSRII in duplicate. For each duplicate sample, 3 × 10 5 -6 × 10 5 total events were scored. Repair frequencies presented are corrected for background events and for transfection efficiency (50-85%). Transfection efficiency was measured by parallel transfection with 0.05 μ g wild-type GFP expression vector, 0.30 μ g control vector and 20 pmol siRNA. For depletion of two gene targets, 10 pmol of each siRNA was used, while single depletion controls received 10 pmol of the target siRNA and 10 pmol of control luciferase siRNA. Data presented represent mean and error bars represent the s.e.m. of between 5 (n = 5) and 11 (n = 11) independent experiments (n values given in figure legends). Statistical methods. Figure legends specify the sample number in terms of the number of replicates within each individual experiment (typically two) and the number of independent experiments (n) that were performed to generate the data presented. For repair frequency statistical analysis, the arithmetic mean of samples collected for independent experiments was calculated and data points for each independent experiment were used to calculate the mean and s.e.m., calculated as s.d./√ n, in which n indicates the number of independent experiments. Differences between sample pairs repair frequencies were analysed by Student's two-tailed unpaired t-test, assuming unequal variance using GraphPad Prism v6.0d software. P values are indicated in each figure legend. Additional statistical analyses are as described in figure legends. No statistical methods were used to predetermine sample size. The experiments were not randomized, and investigators were not blinded to allocation during experiments and outcome assessment. RT-qPCR analysis. RNA from transfected cells was extracted using QIAGEN RNeasy Mini Kit (QIAGEN Sciences) 48 h after transfection. First-strand cDNA analysis was performed on an ABI 7300 Real time PCR System using Power SYBR Green RNA-to C T 1-Step Kit (Applied Biosystems). SYBR green RT-qPCR assays of GAPDH and the siRNA-targeted gene were performed. We used the NIH NCBI Nucleotide utility to generate gene-specific primer sequences for mouse Brca1, Brca2, Rad51, Bard1, Ctip, Slx4, Fanca, Fancd2 and Gapdh. Primers for RT-PCR: Brca1 sense 5′ -ATGAGCTGGAGAGGATGCTG-3′ ;
Brca1 antisense 5′ -CTGGGCAGTTGCTGTCTTCT-3′ ; Brca2 sense 5′ -TCTGCCACTGTGAAAAATGC-3′ ; Brca2 antisense 5′ -TCAAGCTGGGCTG AAGATT-3′ ; Slx4 sense 5′ -GTGGGACGACTGGAATGAGG-3′ ; Slx4 antisense 5′ -GCACCTTTTGGTGTCTCTGG-3′ ; Ctip sense 5′ -AGGAGAAGGAGGGGA CGC-3′ ; Ctip antisense 5′ -TGAAATACCTCGGCGGGTG-3′ ; Fanca sense 5′ -GGCAGCCCTGTACAACTGAT-3′ ; Fanca antisense 5′ -GCCAGCAG CTCTGTCATGTT-3′ ; Fancd2 sense 5′ -CAGATTCGCAGCAGGTTCAC-3′ ; Fancd2 antisense 5′ -ACACACATGCAGAACAGGAT-3′ ; Gapdh sense 5′ -CGTCCCGTAGACAAAATGGT-3′ ; Gapdh antisense 5′ -TCGTTGATGGCAAC AATCTC-3′ . We used the Roche ProbeFinder utility based on Primer 3 software (Whitehead Institute, MIT) to generate gene-specific primer sequences for mouse Fancm and Blm: Fancm sense 5′ -GTCGTTATCCTCGCTGAAGG-3′ ; Fancm antisense 5′ -TTTGTTGGACTGACTCTGATTATATGT-3′ ; Blm sense 5′ -CGCGACGTAAGCCTGAGT-3′ ; Blm antisense 5′ -TGGCTGAGTGTCGCT GTAGT-3′ . mRNA was measured in triplicates. Target gene expression level was normalized to Gapdh and expressed as a fold difference from siLUC-treated sample from the same experiment ( ). Western blotting. Cells were lysed using RIPA buffer (50 mM Tris-HCl, pH 8.0, 250 mM NaCl, 0.1% sodium dodecyl sulphate, 1% NP-40 containing the protease inhibitors, PMSF, and Roche complete protease inhibitor tablet) and resolved by 10% bis-Tris SDS-PAGE (Invitrogen). Protein expression was analysed by immunoblotting using the following antibodies; β -tubulin (Abcam ab6046, 1:4,000), human RAD51 (aliquot B32, 1:500), mouse XRCC4 (Abcam ab97351, 1:3,000). Southern blotting. Southern blotting of BglII-or AseI-digested genomic DNA was performed using a GFP cDNA probe by methods described previously 10, 26, 53 . For all experiments, mouse ES cell clones containing a single, intact copy of the reporter integrated at the Rosa26 locus on chromosome 6 were used. Genomic DNA was extracted from ES cells grown to confluence on gelatinized 6-well plates (~ 5 × 10 6 -10 × 10 6 cells) using a Puregene DNA Isolation Kit (QIAGEN Sciences). Individual repair clone capture and molecular analysis. Individual GFP + RFP -, GFP + RFP + , or GFP -RFP + cells were captured by FACS 72 h after transfection using a FACSAria II SORP running FACSDiva software v6.1.3. To capture aneuploid 'non-disjunction' clones, individual GFP + RFP + or GFP -RFP + cells were FACSsorted 48 h after transfection. Cytochalasin B induced mitotic arrest and nondisjunction, 24 h after transfection cells were incubated for 22 h and FACS-sorted for 2 h in 30 μ M dihydrocytochalasin B (Sigma Aldrich, D1641). Isolated colonies from single cells were picked from 6 cm dishes containing feeder MEFs and individual repair clones expanded onto 24-well plates also containing feeder MEFs. Genomic DNA was extracted from ES clones subsequently expanded and grown to confluence on gelatinized 6-well plates (~ 5 × 10 6 -10 × 10 6 cells) using a Puregene DNA Isolation Kit (QIAGEN Sciences). LTGC and TD breakpoint junction PCR was performed using Taq DNA Polymerase (QIAGEN Sciences) according to manufacturer's instructions using primers unique to HR cassette synthetic RFP exons: RFP exon A sense 5′ -ATGTACGGCTCCAAGGCCTACGTGAAGCAC-3′ ; RFP exon B antisense 5′ -TCGTACTGTTCCACGATGGTGTAGTCCTCG-3′ . Unpurified PCR product sequencing was performed by Eton Bioscience using nested primers: sense 5′ -TGCACGCTTCAAAAGCGCACG-3′ ; antisense 5′ -CAAGTTAACAACAACAATTGCATTC-3′ . TD breakpoint sequence analysis and alignment was performed manually. Exact duplicate clones of individual TDs from within one experiment were removed before subsequent analysis. No exact duplicates of individual TDs were identified between different experiments. LAM-HTGTS sample preparation and analysis. 4 × 10 6 cells mouse ES reporter cells containing a single copy of the 1× GFP Ter/HR reporter cassette targeted to the Rosa26 locus were co-transfected in suspension with 0.35 μ g empty vector, pcDNA3β -myc NLS-Tus, or pcDNA3β -myc NLS-I-SceI, 10 pmol ONTargetPlussmartpool and 0.15 μ g pX330 CRISPR-Cas9 expression plasmid targeting bait sequence ~ 30 kb distant to the Rosa26 locus. CRISPR-Cas9 sgRNA sequence 5′ -GGCAGGAGTAACTTGCTTCC* TGG-3′ , 30 kb distance to Rosa26. Underlined nucleotides identify the positions of the Cas9-induced bait DSB; the asterisk indicates the boundary between the protospacer and PAM sequences. For all conditions, 48 h after transfection, gDNA was isolated using a Puregene DNA Isolation Kit (QIAGEN Sciences) with the following modifications: 2× volume of Protein Precipitation Buffer (QIAGEN Sciences) was added to each sample; samples were gently inverted and never vortexed; protein was removed by consecutive incubations on ice for 30 min followed by 30 min centrifugation, 2,000g, 4 °C; genomic DNA was rehydrated in 125 μ l TE buffer and allowed to dissolve overnight at room temperature; samples were incubated with 13 μ g ml −1 RNase A overnight at 55 °C. 35-50 μ g gDNA for each sample was diluted in a final volume of 100 μ l TE. LAM-HTGTS libraries were prepared and analysed as outlined previously 50 . Primers used: LAM-PCR, CRISPR-Cas9-biotin-GGCGTCACCACATAGTAGGC; on-bead ligation, article reSearcH bridge adaptor-sense-GCGACTATAGGGCACGCGTGGNNNNNN-NH 2 ; bridge-adaptor-antisense 5-PhosCCACGCGTGCCCTATAGTCGC-NH 2 ; nested-PCR, I5-nested-ACACTCTTTCCCTACACGACGCTCTTCCGATCT-5nt barcode-nested primer; CRISPR-Cas9-nested primer-CATGGCGGAAAGTA GATACC, I7-blue-CTCGGCATTCCTGCTGAACCGCTCTTCCGATCTGACT ATAGGGCACGCGTGG; tagged-PCR, P5-I5-AATGATACGGCGACCACCGA GATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT, P7-I7-CAAGCAG AAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCTCTTC. Code availability. The code used to analyse the HTGTS data was published previously 50 . Data availability. The datasets generated during and/or analysed during the current study (for example, the recombination/repair assays analysed throughout the paper, with quantitation by FACS) are available from the corresponding author on reasonable request. Source data for the figures are available in Supplementary  Fig. 1 . The HTGTS datasets (10 datasets, corresponding to a total of 25 independent HTGTS experiments) are deposited in the Gene Expression Omnibus (GEO) repository (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi), accession number GSE103624. or Brca1 ∆/exon11 6× Ter-HR cells depleted of indicated repair proteins. Induction of repair products was calculated relative to siLUC controls (which therefore score as 1). Data represents mean of between eight and ten independent experiments, each experimental data point collected as technical duplicates (replicates: siBRCA1, n = 10; siBARD1, n = 9; siCtIP, n = 9; siBLM, n = 8; siFANCM, n = 9; siBRCA2, n = 8; siFANCA, n = 9; siFANCD2, n = 10; siRAD51, n = 9; siSLX4, n = 9). Numbers denote total number of breakpoints with microhomology ≤ 5, excluding untemplated insertions. Grey line denotes expected microhomology usage by chance alone. c, Strand preference of mismatch correction in 14 homeologous breakpoints (that is, microhomology with internal mismatches) of Tus-Ter-induced TDs from Brca1 ∆/exon11 cells transfected with siRNAs shown. 'C/T' indicates C-T mismatch. A TD site (that is, Ter-proximal or upstream) that underwent mismatch correction is noted. d, Template switches associated with six TD breakpoints. Cartoon format as in Extended Data Fig. 2a . Light grey arrows identify orientation of TD segments relative to the parental reporter. Grey numbers denote position of Ter-proximal sites relative to first Ter site encountered by rightward fork. Black numbers denote breakpoint microhomology use (bp). Template switch insertions as shown. e, Distribution of Ter-proximal sites of TD breakpoints in Brca1 ∆/exon11 cells for each treatment group, relative to first Ter site encountered by rightward fork. 10-bp binned data. Grey area/orange triangles denote 6× Ter array. Bottom, distribution of Ter-proximal TD sites in Brca1 ∆/exon11 6× Ter-HR reporter cells transfected with siFANCM, siBRCA1 or siBLM. The source data are identical to that used for histograms in the top panels, but has been re-presented as 'survival' curves, scoring the probability that a Ter-proximal TD site will be positioned to the right of the nucleotide in question. Hence, all groups at nucleotide position − 800 are at 100% and all reach 0% by position + 300. Mantel-Cox log-rank statistical tests between all pairs are not significant. f, Distribution of 'upstream' sites of TD breakpoints in Brca1 ∆/exon11 cells for each treatment group, relative to splice acceptor of RFP exon B. 100-bp binned data. Corresponding author(s): Ralph Scully
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Experimental design 1. Sample size
Describe how sample size was determined. Each experiment contributed one data point to a given value. A sample size of n=6 means that the data shown represents (for example) the mean value of 6 independent experiments. We used the number of experiments to calculate the P value for a given experiment. Statistical methods are reported in the "Methods" section.
Data exclusions
Describe any data exclusions.
We excluded experiments in which the transfection efficiency was less than 40%. These were pre-established criteria, based on our previous experience.
Replication
Describe whether the experimental findings were reliably reproduced.
Yes, on numerous independent experiments and over an extended period of time, using several distinct cell types (as detailed in the m/s).
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Most experiments shown entailed parallel treatments of the same cell line. In these cases, randomization is not applicable.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Not blinded.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
